Amedisys Reports Fourth Quarter and Year-End 2023 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. DECK
2. RNG
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to Amedisys Reports Fourth Quarter and Year-End 2023 Financial Results

Amedisys (AMED) Misses Q4 EPS by 9c

February 21, 2024 4:34 PM EST

Amedisys (NASDAQ: AMED) reported Q4 EPS of $0.94, $0.09 worse than the analyst estimate of $1.03. Revenue for the quarter came in at $570.8 million versus the consensus estimate of $567.4 million.

For earnings history and earnings-related data on Amedisys (AMED) click here.

... More